DeepMed Research

Alliance for Clinical Trials in Oncology

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 2011-01-01

Employees: 251

Market Cap: -

Website: https://www.allianceforclinicaltrialsinoncology.org

Clinical Trials

Biomarkers in Predicting Response in Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy

Completed

Conditions: Lung Cancer

Interventions: Other: Laboratory Biomarker Analysis

First Posted Date: 2011-02-11

Last Posted Date: 2021-01-20

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 241

Registration Number: NCT01294280

Locations: 🇺🇸
SUNY Upstate Medical University, Syracuse, New York, United States

Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia

Completed

Conditions: Leukemia

Interventions: Genetic: DNA analysis
Genetic: fluorescence in situ hybridization
Genetic: gene expression analysis
Genetic: microarray analysis
Genetic: mutation analysis
Genetic: polymerase chain reaction
Other: laboratory biomarker analysis

First Posted Date: 2011-01-26

Last Posted Date: 2020-02-20

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 200

Registration Number: NCT01284010

Locations: 🇺🇸
Cancer and Leukemia Group B, Chicago, Illinois, United States

Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer

Phase 3

Terminated

Conditions: Cognitive/Functional Effects
Colorectal Cancer
Neurotoxicity

Interventions: Biological: bevacizumab
Drug: capecitabine
Drug: fluorouracil
Drug: leucovorin calcium
Drug: oxaliplatin

First Posted Date: 2011-01-19

Last Posted Date: 2017-12-08

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 32

Registration Number: NCT01279681

Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With Ketoconazole

Withdrawn

Conditions: Prostate Cancer

Interventions: Other: laboratory biomarker analysis

First Posted Date: 2011-01-12

Last Posted Date: 2019-01-24

Lead Sponsor: Alliance for Clinical Trials in Oncology

Registration Number: NCT01275651

Locations: 🇺🇸
Alliance for Clinical Trials in Oncology, Boston, Massachusetts, United States

Biomarkers in Predicting Response to Cetuximab in Patients With Advanced Colorectal Cancer

Completed

Conditions: Colorectal Cancer

Interventions: Genetic: mutation analysis
Other: laboratory biomarker analysis

First Posted Date: 2010-11-18

Last Posted Date: 2020-07-24

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 1142

Registration Number: NCT01243372

Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance

Phase 3

Completed

Conditions: Prostate Cancer

Interventions: Other: prostate cancer foundation booklet
Other: dietary education and counseling

First Posted Date: 2010-11-10

Last Posted Date: 2023-03-21

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 478

Registration Number: NCT01238172

Locations: 🇺🇸
Loma Linda University Cancer Institute at Loma Linda University Medical Center, Loma Linda, California, United States
🇺🇸
Elkhart General Hospital, Elkhart, Indiana, United States
🇺🇸
St. Luke's Regional Medical Center, Sioux City, Iowa, United States

and more 177 locations

Vitamin D and Breast Cancer Biomarkers in Female Patients

Phase 3

Completed

Conditions: Breast Cancer

Interventions: Dietary Supplement: vitamin D
Other: placebo

First Posted Date: 2010-10-20

Last Posted Date: 2024-10-08

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 300

Registration Number: NCT01224678

Locations: 🇺🇸
McDonough District Hospital, Macomb, Illinois, United States
🇺🇸
Eureka Community Hospital, Eureka, Illinois, United States
🇺🇸
Galesburg Clinic, PC, Galesburg, Illinois, United States

and more 99 locations

Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy

Phase 3

Completed

Conditions: Gastrointestinal Complications
Diarrhea
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Other: placebo
Drug: sulfasalazine

First Posted Date: 2010-09-09

Last Posted Date: 2020-05-12

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 87

Registration Number: NCT01198145

Locations: 🇺🇸
Boulder Community Hospital, Boulder, Colorado, United States
🇺🇸
Penrose Cancer Center at Penrose Hospital, Colorado Springs, Colorado, United States
🇺🇸
St. Joseph Hospital, Denver, Colorado, United States

and more 252 locations

Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

Phase 2

Completed

Conditions: Lymphoma

Interventions: Biological: ofatumumab

First Posted Date: 2010-08-27

Last Posted Date: 2021-08-18

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 51

Registration Number: NCT01190449

Locations: 🇺🇸
Oncology Hematology Associates of Central Illinois, PC - Ottawa, Ottawa, Illinois, United States
🇺🇸
Illinois CancerCare - Community Cancer Center, Normal, Illinois, United States
🇺🇸
Methodist Medical Center of Illinois, Peoria, Illinois, United States

and more 45 locations

Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer

Phase 3

Terminated

Conditions: Colorectal Cancer

Interventions: Biological: bevacizumab
Biological: cetuximab
Drug: FOLFIRI regimen
Drug: FOLFOX regimen
Drug: capecitabine
Drug: fluorouracil
Drug: irinotecan hydrochloride
Drug: leucovorin calcium
Drug: oxaliplatin
Drug: mitomycin C
Procedure: therapeutic conventional surgery

First Posted Date: 2010-07-22

Last Posted Date: 2024-12-27

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 340

Registration Number: NCT01167725

Locations: 🇺🇸
St. Agnes Hospital Cancer Center, Baltimore, Maryland, United States
🇺🇸
Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy